Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer

被引：0
|
作者：
Krieger, G
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2001年 / 177卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：316 / 318
页数：3
相关论文
共 50 条
  • [21] Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancer
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Brandi, Giovanni
    LANCET ONCOLOGY, 2022, 23 (01): : E11 - E11
  • [22] Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
    Suenaga, Mitsukuni
    Mizunuma, Nobuyuki
    Shouji, Daigo
    Shinozaki, Eiji
    Matsusaka, Satoshi
    Chin, Keisho
    Oya, Masatoshi
    Yamaguchi, Toshiharu
    Muto, Tetsuichiro
    Hatake, Kiyohiko
    JOURNAL OF GASTROENTEROLOGY, 2008, 43 (11) : 842 - 848
  • [23] Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
    Mitsukuni Suenaga
    Nobuyuki Mizunuma
    Daigo Shouji
    Eiji Shinozaki
    Satoshi Matsusaka
    Keisho Chin
    Masatoshi Oya
    Toshiharu Yamaguchi
    Tetsuichiro Muto
    Kiyohiko Hatake
    Journal of Gastroenterology, 2008, 43 : 842 - 848
  • [24] Efficacy of bevacizumab plus bolus irinotecan, fluorouracil and leucovorin (IFL-BV) for highly pretreated metastatic colorectal cancer (MCRC)
    Carrera, S.
    Munoz, A.
    Gil-Negrete, A.
    Rubio, I
    Ancizar, N.
    Calvo, B.
    Fuente, N.
    Barcelo, R.
    Janhi, M.
    Lopez-Vivanco, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 68 - 68
  • [25] Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer
    McWilliams, Robert R.
    Goetz, Matthew P.
    Morlan, Bruce W.
    Salim, Muhammad
    Rowland, Kendrith M.
    Krook, James E.
    Ames, Matthew M.
    Erlichman, Charles
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 516 - 521
  • [26] Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
    Sargent, DJ
    Niedzwiecki, D
    O'Connell, MJ
    Schilsky, RL
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (02): : 144 - 145
  • [27] Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer
    Sheikh, H. Y.
    Valle, J. W.
    Waddell, T.
    Palmer, K.
    Wilson, G.
    Sjursen, A.
    Craven, O.
    Swindell, R.
    Saunders, M. P.
    BRITISH JOURNAL OF CANCER, 2008, 99 (04) : 577 - 583
  • [28] Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer
    H Y Sheikh
    J W Valle
    T Waddell
    K Palmer
    G Wilson
    A Sjursen
    O Craven
    R Swindell
    M P Saunders
    British Journal of Cancer, 2008, 99 : 577 - 583
  • [29] Meta-analysis comparing the safety and efficacy of metastatic colorectal cancer treatment regimens, capecitabine plus irinotecan (CAPIRI) and 5-fluorouracil/leucovorin plus irinotecan (FOLFIRI)
    Ding, Hong-hua
    Wu, Wei-dong
    Jiang, Tao
    Cao, Jun
    Ji, Zheng-yi
    Jin, Jia-huan
    Wang, Jing-jue
    Song, Wei-feng
    Wang, Li-wei
    TUMOR BIOLOGY, 2015, 36 (05) : 3361 - 3369
  • [30] Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancer reply
    Yoo, Changhoon
    LANCET ONCOLOGY, 2022, 23 (01): : E12 - E12
12345